BiotechTube
Home/Teva/Sven Dethlefs
SD

Sven Dethlefs

Executive Vice President, Global Marketing and Access

Teva

Roles

Executive Vice President, Global Marketing and AccessatTeva
Executive Vice President, Global Marketing & AccessatTeva Pharmaceutical Industries

Therapeutic Areas

NeuroscienceImmunology

Teva Pipeline

DrugIndicationPhase
Biosimilar to Xgeva® (denosumab)Oncology (bone metastases)Approved/Under Review
Biosimilar to Prolia® (denosumab)OsteoporosisApproved/Under Review
Biosimilar to Simponi® (golimumab)Inflammatory DiseasesUnder Regulatory Review
Biosimilar to Xolair® (omalizumab)Asthma, Chronic Spontaneous UrticariaFiled
TEV-'574 (or similar)Ulcerative Colitis, Crohn’s DiseasePhase 3
Asthma CandidateAsthmaPhase 3
Schizophrenia CandidateSchizophreniaPhase 3
MSA CandidateMultiple System AtrophyPhase 2

Leadership Team at Teva

RF
Richard Francis
President and Chief Executive Officer
E(
Eli (Evan) Lippman
Executive Vice President, Business Development
ED
Eric Drape
Executive Vice President and Chief Financial Officer
HF
Hafrun Fridriksdottir
Executive Vice President, Global R&D
View full Teva profile